A Phase 1B, Open-Label Study of the Safety and Tolerability of Atezolizumab in Combination with Radium-223 Dichloride in Patients with Castrate-Resistant Prostate Cancer who have progressed followinIn
Clinical Trial Grant
Awarded By
Genentech, Inc.
Start Date
March 2, 2017
End Date
September 7, 2021
Awarded By
Genentech, Inc.
Start Date
March 2, 2017
End Date
September 7, 2021